KYNTRA BIO, INC. (KYNB) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2014: $242.85M2015: $273.75M2016: $294.44M2017: $350.91M2018: $352.13M2019: $321.99M2020: $385.39M2021: $544.71M2022: $611.57M2023: $585.73M2024: $398.16M2025: $115.12M$115.12M
2014Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$115.12M-71.1%
2024$398.16M-32.0%
2023$585.73M-4.2%
2022$611.57M+12.3%
2021$544.71M+41.3%
2020$385.39M+19.7%
2019$321.99M-8.6%
2018$352.13M+0.3%
2017$350.91M+19.2%
2016$294.44M+7.6%
2015$273.75M+12.7%
2014$242.85M